Stock 0C1 ATRECA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Atreca, Inc.

Equities

0C1

US04965G1094

Biotechnology & Medical Research

Delayed Deutsche Boerse AG
Other stock markets
 19:58:21 28/03/2024 GMT 		5-day change 1st Jan Change
0.0435 EUR -62.17% Intraday chart for Atreca, Inc. -.--% -62.17%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 409.3 568.8 114.4 32.82 1.863 1.863 -
Enterprise Value (EV) 1 409.3 568.8 114.4 32.82 1.863 1.863 1.863
P/E ratio - - - - - - -
Yield - - - - - - -
Capitalization / Revenue - - - - - - -
EV / Revenue - - - - - - -
EV / EBITDA - -6,575,433 x -1,081,798 x - - - -
EV / FCF -6,603,408 x - -1,191,578 x -402,186 x - - -
FCF Yield -0% - -0% -0% - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 27,961 36,707 37,151 39,067 39,653 39,653 -
Reference price 2 13.20 12.60 2.720 0.7850 0.0435 0.0435 0.0435
Announcement Date 11/03/20 25/02/21 03/03/22 29/03/23 - - -
1EUR in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 - - - - - - - -
EBITDA - - -86.5 -105.8 - - - -
EBIT 1 - -72.57 -88.88 -110.3 -98.3 -66.3 -39.5 -49
Operating Margin - - - - - - - -
Earnings before Tax (EBT) 1 - -67.48 -86.33 -109.3 -97.16 -64.6 -38.5 -48
Net income 1 -37.94 -67.48 -86.34 -109.3 -97.16 -64.6 -38.5 -48
Net margin - - - - - - - -
EPS - - - - - - - -
Free Cash Flow - -61.98 - -96.01 -81.61 - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 24/04/19 11/03/20 25/02/21 03/03/22 29/03/23 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - - - - - - - - - - - -
EBITDA -27.07 -26.1 -28.14 -25.67 -28.03 -21.93 - -21.53 -18.47 -14.88 - - - - -
EBIT 1 -27.07 -27.52 -29.51 -25.67 -28.03 -23.29 -21.3 -21.53 -19.75 -15.79 -9.2 -9 -9.8 -10 -10.8
Operating Margin - - - - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -26.67 -27.36 -29.52 -24.88 -27.88 -23.06 -21.34 -21.01 -19.19 -36.22 -8.8 -8.8 -9.5 -9.8 -10.5
Net income 1 -26.68 -27.36 -29.52 -24.88 -27.88 -23.06 -21.34 -21.01 -19.19 -36.22 -8.8 -8.8 -9.5 -9.8 -10.5
Net margin - - - - - - - - - - - - - - -
EPS - - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/08/21 02/11/21 03/03/22 11/05/22 08/08/22 10/11/22 29/03/23 10/05/23 10/08/23 14/11/23 - - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - -62 - -96 -81.6 - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - 3.45 5.03 35.1 0.89 - - -
Capex / Sales - - - - - - - -
Announcement Date 24/04/19 11/03/20 25/02/21 03/03/22 29/03/23 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ATRECA, INC. Stock Atreca, Inc.
-62.17% 1.84M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+16.49% 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+21.73% 115B
ARGENX SE Stock argenx SE
+22.18% 26.64B
BIONTECH SE Stock BioNTech SE
-21.81% 19.91B
GENMAB A/S Stock Genmab A/S
-16.89% 16.32B
BEIGENE, LTD. Stock BeiGene, Ltd.
-18.81% 15.49B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-44.74% 15.52B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+62.72% 14.83B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.09% 13.67B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 0C1 Stock
  4. Financials Atreca, Inc.